FDA Approves Epsolay (benzoyl peroxide) Cream for the Treatment of Rosacea
NESS ZIONA, Israel and ZUG, Switzerland, April 25, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Dermatology | Drugs & Pharmacology | Israel Health | Middle East Health | Rosacea | Skin | Switzerland Health